USD10
Acciones de CPRX
Acerca de Catalyst PharmaceuticalsCatalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.
USD10
Acciones de CPRX
Acerca de Catalyst PharmaceuticalsCatalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.
Estadísticas
VENTANA DE TRADING
Cerrado
ABRE A LAS
No hay datos suficientes
CAP. DE MERCADO
2796,64 M US$
PRECIO DE APERTURA
22,42 US$
MÍNIMO (1 A)
19,05 US$
MÁXIMO (1 A)
26,58 US$
MÍNIMO (24 h)
22,16 US$
MÁXIMO (24 h)
22,87 US$
VOLUMEN (24 h)
3,19 M US$
206,44 %
Historial de precios
Time | Price | Change |
|---|---|---|
Hoy | 22,42 US$ | |
1 día | 22,73 US$ | |
1 semana | 23,23 US$ | |
1 mes | 24,50 US$ | |
1 año | 25,74 US$ |